CC-92480
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CC-92480, covering 2024-11-29 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) [Phase 1, Phase 2]